Public consultation now open

◄ Back to Transfusion News

The National Blood Authority (NBA) is inviting comment on proposed changes to the Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia (the Criteria) developed by governments using expert Specialist Working Groups of clinicians to identify the medical conditions and circumstances for which immunoglobulin product is supplied and funded by all Australian governments under the national blood arrangements.

Public consultation will be open until  9 June 2017.

The Blood Service would like to encourage you to visit the NBA website to find out about the proposed changes and how you can provide feedback.